{"id":1259,"date":"2007-12-07T02:00:00","date_gmt":"2007-12-07T00:00:00","guid":{"rendered":"http:\/\/92.45.35.169\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/"},"modified":"2024-07-03T15:04:52","modified_gmt":"2024-07-03T12:04:52","slug":"pfizer-turkiye-ik-direktoru-yesim-ozyurtcu","status":"publish","type":"post","link":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/","title":{"rendered":"Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc ‘Ye\u015fim \u00d6zyurt\u00e7u’"},"content":{"rendered":"
<\/p>\n
\"\"Pfizer, markas\u0131n\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fc ve hayata ge\u00e7irdi\u011fi \u0130K uygulamalar\u0131yla yeti\u015fmi\u015f \u0130nsan Kayna\u011f\u0131n\u0131 b\u00fcnyesine \u00e7ekebiliyor. Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc Ye\u015fim \u00d6zyurt\u00e7u, “Pfizer, ba\u015far\u0131s\u0131n\u0131n ard\u0131nda yatan en \u00f6nemli fakt\u00f6r\u00fcn, \u00e7al\u0131\u015fanlar\u0131 oldu\u011funa ve gelecekteki ba\u015far\u0131s\u0131n\u0131n kayna\u011f\u0131n\u0131n da \u00e7al\u0131\u015fanlar\u0131 olaca\u011f\u0131n\u0131n bilincinde olan bir \u015firket.” diyor.<\/span><\/strong><\/div>\n
1957’den beri T\u00fcrkiye’de imalat yapan Pfizer,2000’li y\u0131llarla beraber t\u0131p d\u00fcnyas\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an yenilik\u00e7i tedavileri t\u0131bb\u0131n\u0131n hizmetine sunmaya devam ediyor.<\/span><\/strong>\u0130la\u00e7 sekt\u00f6r\u00fc, son d\u00f6nemde, h\u0131zl\u0131 de\u011fi\u015fim g\u00f6steren sekt\u00f6rlerden biri olarak \u00f6ne \u00e7\u0131k\u0131yor. Sonu\u00e7 olarak ila\u00e7 sekt\u00f6r\u00fcne olan ilgi giderek art\u0131yor. \u0130nsanlar\u0131n daha sa\u011fl\u0131kl\u0131 ve kaliteli bir ya\u015fam s\u00fcrmesi i\u00e7in ke\u015ffedilen ila\u00e7lar\u0131n ve yeni tedavilerin, d\u00fcnya \u00fczerinde ya\u015fayan milyarlarca insana ula\u015ft\u0131r\u0131lmas\u0131 d\u00fc\u015f\u00fcncesi \u00f6zellikle yeni mezun gen\u00e7lere son derece cazip geliyor. Pfizer’in s\u00fcrd\u00fcrd\u00fc\u011f\u00fc \u0130K uygulamalar\u0131, y\u00f6netim anlay\u0131\u015f\u0131 ve sunulan imkanlar da \u00e7al\u0131\u015fanlar\u0131n uzun y\u0131llar Pfizer’de kalmas\u0131n\u0131 m\u00fcmk\u00fcn k\u0131l\u0131yor.  Pfizer T\u00fcrkiye \u0130K uygulamalar\u0131n\u0131, \u0130K Direkt\u00f6r\u00fc Ye\u015fim \u00d6zyurt\u00e7u anlat\u0131yor. <\/span><\/div>\n

\u0130K departman\u0131 ne zaman kuruldu? Pfizer’in ba\u015far\u0131s\u0131nda \u0130K’n\u0131n yeri nedir?<\/span><\/strong>
\u0130lk kuruldu\u011funda Pfizer’de Personel Diviyonu vard\u0131, sendikal ili\u015fkiler ve operasyonel i\u015fler \u00f6n plandayd\u0131. 80’li y\u0131llarda end\u00fcstrinin de geli\u015fmesiyle \u0130K da \u015fekil de\u011fi\u015ftirdi. Bilgi ve rekabet \u00e7a\u011f\u0131nda kurumlar, ba\u015far\u0131l\u0131 olabilmek i\u00e7in her \u00e7al\u0131\u015fan\u0131n\u0131n beyin g\u00fcc\u00fcnden, yetkinliklerinden faydalan\u0131lmal\u0131. Motivasyon ve sahiplenme olmaks\u0131z\u0131n \u00e7al\u0131\u015fanlar\u0131n \u015firkete katma de\u011fer yaratmas\u0131 y\u00fcksek performans ve \u00e7aba g\u00f6stermeleri \u00e7ok zor. \u015eirketlerin rekabet avantaj\u0131n\u0131 s\u00fcrd\u00fcrebilmeleri, \u00e7al\u0131\u015fanlar\u0131n\u0131n memnuniyeti ve \u00f6zellikle y\u00fcksek performansl\u0131 \u00e7al\u0131\u015fanlar\u0131n\u0131n \u015firkette kalma s\u00fcreleriyle do\u011frudan ilgili. D\u00fcnyada bu konuda yap\u0131lan ara\u015ft\u0131rmalar, \u00e7al\u0131\u015fan ba\u011fl\u0131l\u0131\u011f\u0131n\u0131n m\u00fc\u015fteri memnuniyeti, \u015firket performans\u0131, finansal sonu\u00e7lar\u0131 ve karl\u0131l\u0131\u011f\u0131yla do\u011fru orant\u0131l\u0131 oldu\u011funu g\u00f6steriyor. Pfizer, ba\u015far\u0131s\u0131n\u0131n ard\u0131nda yatan en \u00f6nemli fakt\u00f6r\u00fcn, \u00e7al\u0131\u015fanlar\u0131 oldu\u011funa ve gelecekteki ba\u015far\u0131s\u0131n\u0131n kayna\u011f\u0131n\u0131n da \u00e7al\u0131\u015fanlar\u0131 olaca\u011f\u0131n\u0131n bilincinde olan bir \u015firket. <\/span><\/div>\n

\u0130K olarak hangi g\u00f6revleri y\u00fcr\u00fct\u00fcyorsunuz? Bu g\u00f6revlerin y\u00fcr\u00fct\u00fclmesi i\u00e7in nas\u0131l bir i\u00e7 yap\u0131lanman\u0131z var? <\/span><\/strong>
\u0130nsan Kaynaklar\u0131 departman\u0131nda 15 ki\u015fi \u00e7al\u0131\u015f\u0131yoruz. Pfizer T\u00fcrkiye \u0130K’s\u0131; \u0130K Operasyonlar\u0131yla \u0130K Stratejileri ve Organizasyonel Geli\u015fim Departmanlar\u0131 olmak \u00fczere iki ana departmandan olu\u015fuyor. \u0130K olarak y\u00fcr\u00fctt\u00fc\u011f\u00fcm\u00fcz ana g\u00f6revler; i\u015fe al\u0131m, performans ve kariyer y\u00f6netimi, e\u011fitim ve geli\u015fim, i\u00e7 ileti\u015fim, maa\u015f ve sosyal yan haklar y\u00f6netimi, personel \u00f6zl\u00fck i\u015fleri, organizasyonel geli\u015fim, idari i\u015fler, end\u00fcstriyel ve sendikal ili\u015fkiler olarak s\u0131ralanabilir. \u0130K olarak amac\u0131m\u0131z; \u015eirketin hedef\/strateji belirleme ve y\u00f6netim s\u00fcre\u00e7lerinin i\u00e7inde stratejik ortak olarak yer almak, t\u00fcm y\u00f6neticilerimizin birer insan kaynaklar\u0131 y\u00f6neticisi olarak hareket etmelerini sa\u011flamak, \u00e7al\u0131\u015fanlar\u0131n geli\u015fimlerine y\u00f6n veren bir dan\u0131\u015fma merkezi olmak, \u0130nsan kaynaklar\u0131 y\u00f6netim sistemlerinin etkin olarak i\u015flemesini sa\u011flamak. <\/span><\/div>\n

Yak\u0131n vadede ger\u00e7ekle\u015ftirmek istedi\u011finiz projeleriniz neler? <\/span><\/strong>
Bu seneki \u00f6nemli odaklar\u0131m\u0131zdan biri \u015firket i\u00e7i mentorluk sisteminin olu\u015fturulmas\u0131, geli\u015fim ortam\u0131n\u0131n g\u00fc\u00e7lendirilmesi ve e\u011fitime a\u011f\u0131rl\u0131k verilmesi. Amac\u0131m\u0131z Pfizer’i daha da ileri ta\u015f\u0131yacak ki\u015fileri gelece\u011fe haz\u0131rlamak. Ayr\u0131ca global \u0130K sistemlerimizin lokal uygulama \u00e7al\u0131\u015fmalar\u0131 h\u0131zla devam ediyor. T\u00fcm Pfizer’lerde ge\u00e7erli olacak Global Performans Sistemi, Global Kariyer Planlama gibi sistemlerle i\u015flerimize art\u0131k daha geni\u015f pencereden bak\u0131yoruz. Ayr\u0131ca, Pfizer T\u00fcrkiye olarak bu sene Kurumsal Film Festivali’ne kat\u0131l\u0131yoruz. T\u00fcrkiye’deki 50. y\u0131l\u0131m\u0131z\u0131 kutlad\u0131\u011f\u0131m\u0131z bu anlaml\u0131 senede, \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n senaryosunu yaz\u0131p, oynayaca\u011f\u0131, \u00e7ekece\u011fi ve sonunda Kurumsal Film Festivali’nde yar\u0131\u015facak filmlerle kal\u0131c\u0131 bir iz b\u0131rakmay\u0131 hedefledik. Festivale kat\u0131lmam\u0131zdaki di\u011fer bir hedefse yetenekli \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131 ke\u015ffetmek ve bu e\u011flenceli ve \u00f6zel tak\u0131m \u00e7al\u0131\u015fmas\u0131 ile motivasyonu art\u0131rmak. Festivale Fantastik Film\/Uyarlama ve Reklam Filmi kategorilerinde kat\u0131l\u0131yoruz. Her 2 kategoride de olduk\u00e7a iddial\u0131y\u0131z. Bu sene ba\u015flayan \u00f6nemli projelerimizden bir di\u011feri de ofislerimizin yenilenmesi. Ortak\u00f6y gibi \u00e7ok be\u011fenilen ve merkezi bir yerde bulunan merkez ofisimizi hem depreme kar\u015f\u0131 g\u00fc\u00e7lendiriyor, hem de i\u00e7 mekanlar\u0131m\u0131z\u0131 yenilemeye ba\u015fl\u0131yoruz. Bu s\u00fcreci t\u00fcm \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n katk\u0131 ve sahiplenmesiyle keyifli bir \u015fekilde y\u00fcr\u00fctebilmek i\u00e7in de bir ileti\u015fim plan\u0131 y\u00fcr\u00fctece\u011fiz. Organizasyonel geli\u015fim, \u00e7al\u0131\u015fanlarla ileti\u015fim ve e\u011fitimin daha fazla \u00f6n plana \u00e7\u0131kaca\u011f\u0131n\u0131 d\u00fc\u015f\u00fcn\u00fcyorum.<\/span><\/div>\n

Pfizer’nin g\u00fcven veren imaj\u0131n\u0131 insan kaynaklar\u0131 departman\u0131 olarak nas\u0131l destekliyorsunuz? <\/span><\/strong>
\u0130nsanlar\u0131n daha sa\u011fl\u0131kl\u0131, daha uzun ve kaliteli bir ya\u015fam s\u00fcrmesi i\u00e7in \u00e7al\u0131\u015f\u0131yoruz. Ar-Ge oda\u011f\u0131m\u0131z ve yat\u0131r\u0131mlar\u0131m\u0131z sayesinde ke\u015ffetti\u011fimiz ve t\u0131bb\u0131n hizmetine sundu\u011fumuz yenilik\u00e7i ila\u00e7lar\u0131m\u0131zla insan hayat\u0131n\u0131 tehdit eden bir\u00e7ok hastal\u0131\u011f\u0131n tedavisinde \u00f6nemli ad\u0131mlar att\u0131k. D\u00fcnyada en \u00e7ok Ar-Ge yat\u0131r\u0131m\u0131 yapan ila\u00e7 \u015firketi olarak insanl\u0131\u011f\u0131 tehdit eden hastal\u0131klarla m\u00fccadele i\u00e7in \u00e7al\u0131\u015fmalar\u0131m\u0131z\u0131 s\u00fcrd\u00fcr\u00fcyoruz. Bilimsel tecr\u00fcbemiz ve bu alana yapt\u0131\u011f\u0131m\u0131z yat\u0131r\u0131mla y\u0131llar i\u00e7erisinde sa\u011fl\u0131k mesle\u011fi mensuplar\u0131 ve kamuoyunda g\u00fcven ve itibar\u0131m\u0131z\u0131 peki\u015ftirdik. Pfizer markas\u0131n\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fc ve hayata ge\u00e7irdi\u011fimiz \u0130K uygulamalar\u0131yla yeti\u015fmi\u015f \u0130nsan Kaynaklar\u0131n\u0131 b\u00fcnyemize \u00e7ekebiliyoruz. Ayr\u0131ca Pfizer’in sundu\u011fu yurtd\u0131\u015f\u0131nda kariyer imkanlar\u0131 da bunu destekliyor. <\/span><\/div>\n

Performans de\u011ferlendirme s\u00fcreciniz nas\u0131l i\u015fliyor?<\/span><\/strong>
Bireysel geli\u015fim, y\u00fcksek performans ve ba\u015far\u0131 i\u00e7in t\u00fcm olanaklar yarat\u0131l\u0131yor. Pfizer’de uygulanan Performans Sisteminin as\u0131l amac\u0131; \u015firketimizin vizyonu do\u011frultusunda hedeflerine ula\u015fmas\u0131nda \u00e7al\u0131\u015fanlar\u0131n kat\u0131l\u0131mlar\u0131n\u0131n adil, sistemli ve \u00f6l\u00e7\u00fclebilir bir y\u00f6ntemle de\u011ferlendirilmesi ve motive edici bir \u00e7al\u0131\u015fma ortam\u0131 olu\u015fturarak ki\u015fisel geli\u015fimin desteklenmesi. Y\u0131ll\u0131k performans de\u011ferlendirme s\u00fcreci, \u015firket vizyon ve de\u011ferleri do\u011frultusunda bir sonraki y\u0131la ait \u015firket hedefleri ve a\u011f\u0131rl\u0131klar\u0131n \u00fcst y\u00f6netim taraf\u0131ndan belirlenmesiyle ba\u015fl\u0131yor. \u015eirket hedefleri, takiben divizyon, birim ve ki\u015fisel hedeflerine indirgenir. Pfizer’de performans de\u011ferlendirmesi ba\u015far\u0131n\u0131n \u00f6n\u00fcn\u00fc a\u00e7acak bi\u00e7imde \u015fekillendiriliyor. Y\u0131l ortas\u0131ndaki ara g\u00f6r\u00fc\u015fmesi ve y\u0131lsonu de\u011ferlendirmesinde, sergilenen performansa kar\u015f\u0131l\u0131k gelen de\u011ferlendirme ve ki\u015fisel geli\u015fim planlar\u0131 ki\u015fi ve y\u00f6neticisi ile birlikte ger\u00e7ekle\u015ftiriliyor. Performans sistemi, hem ki\u015fisel ba\u015far\u0131n\u0131n hem de \u015firket ba\u015far\u0131s\u0131n\u0131n artt\u0131r\u0131lmas\u0131nda \u00e7ok \u00f6nemli ve etkili bir ara\u00e7 oldu\u011fundan, performans\u0131n izlenmesi ve etkin \u015fekilde de\u011ferlendirilmesi sistemin ama\u00e7lar\u0131na ula\u015fmas\u0131 i\u00e7in kritiktir. Pfizer’de performans de\u011ferlendirmesi ba\u015far\u0131n\u0131n \u00f6n\u00fcn\u00fc a\u00e7acak bi\u00e7imde \u015fekillendirilmektedir ve ki\u015fisel geli\u015fimi desteklemeye odakl\u0131d\u0131r. Pfizer’de hedef, iyi bir performans sistemi uygulamas\u0131yla \u00e7al\u0131\u015fanlara geli\u015fim olanaklar\u0131 sa\u011flamak ve motive edici bir ortam yaratarak performans\u0131 s\u00fcrekli artt\u0131rmakt\u0131r. <\/span><\/div>\n

\u00c7al\u0131\u015fanlar\u0131n\u0131n yaln\u0131zca \u00e7al\u0131\u015ft\u0131klar\u0131 s\u00fcre\u00e7te de\u011fil emeklilik d\u00f6neminde de ek gelir elde etmesi ve refah d\u00fczeylerinin y\u00fckselmesi hedefiyle, “\u015eirket Katk\u0131l\u0131 Bireysel Emeklilik Plan\u0131”n\u0131 uygulan\u0131yor.<\/font><\/span><\/div>\n

Motivasyon ad\u0131na ne gibi \u00e7al\u0131\u015fmalar yap\u0131yorsunuz? <\/span><\/strong>
\u00c7al\u0131\u015fanlar\u0131n motivasyonunu y\u00fckseltmek i\u00e7in ger\u00e7ekle\u015ftirilen faaliyetler, Pfizer’in “\u00d6nde gelen i\u015fveren” vizyonu do\u011frultusunda tasarlan\u0131yor. \u00c7al\u0131\u015fanlar\u0131n\u0131n yaln\u0131zca \u00e7al\u0131\u015ft\u0131klar\u0131 s\u00fcre\u00e7te de\u011fil emeklilik d\u00f6neminde de ek gelir elde etmesi ve refah d\u00fczeylerinin y\u00fckselmesi hedefiyle, “\u015eirket Katk\u0131l\u0131 Bireysel Emeklilik Plan\u0131”n\u0131 uygulamaya ge\u00e7ti. Pfizer Sosyal Kul\u00fcpleri’nde g\u00f6n\u00fcll\u00fcl\u00fck esas\u0131na dayanarak kurulan kul\u00fcpler, \u00e7al\u0131\u015fanlar aras\u0131ndaki etkile\u015fimi art\u0131r\u0131yor. \u015eirketimizdeki i\u015f-\u00f6zel ya\u015fam dengesine destek olmak amac\u0131yla “Esnek \u00c7al\u0131\u015fma Saatleri” uygulan\u0131yor. \u00c7al\u0131\u015fanlar\u0131m\u0131z\u0131 keyifli bir ortamda bir araya getirebilmek, beraber g\u00fczel zaman ge\u00e7irebilmek ve i\u015f stresini biraz olsun azaltabilmek i\u00e7in “teras partileri” d\u00fczenleniyoruz. 2005’ten itibaren her ay ger\u00e7ekle\u015ftirilen “do\u011fum g\u00fcn\u00fc kahvalt\u0131lar\u0131”nda o ay do\u011fan \u00e7al\u0131\u015fanlar\u0131m\u0131z ve genel m\u00fcd\u00fcr\u00fcm\u00fcz bir araya gelerek, sohbet edip, ortak payla\u015f\u0131m alanlar\u0131 yarat\u0131l\u0131yor. <\/span><\/div>\n

\u00c7al\u0131\u015fanlar\u0131n\u0131za ne t\u00fcr e\u011fitimler veriyorsunuz?<\/span><\/strong>
\u00c7al\u0131\u015fanlara sa\u011flanan e\u011fitim programlar\u0131, ki\u015finin hem bulundu\u011fu pozisyonda geli\u015fmesini ve i\u015fini en iyi \u015fekilde yapabilmesini sa\u011flamak; hem de ki\u015fiyi ilerideki olas\u0131 pozisyonlara haz\u0131rlamak odakl\u0131. E\u011fitim ve geli\u015fim programlar\u0131yla amac\u0131m\u0131z \u00e7al\u0131\u015fanlar\u0131n kendilerini geli\u015ftirmeleri, iyi birer lider olarak yeti\u015fmeleri i\u00e7in gerekli olan anahtar yetkinlikleri belirlemek, sa\u011flamak ve geli\u015ftirmek. Pfizer i\u00e7i e\u011fitim programlar\u0131 ve Pfizer uluslararas\u0131 programlar\u0131n\u0131n yan\u0131 s\u0131ra; yurt i\u00e7inde ve yurt d\u0131\u015f\u0131nda Insead, Harvard Business School gibi sayg\u0131n \u00fcniversiteler, Center for Creative Leadership, Management Centre Europe gibi se\u00e7kin e\u011fitim \u015firketleriyle ortak \u00e7al\u0131\u015fmalar y\u00fcr\u00fct\u00fcl\u00fcyor. E\u011fitim programlar\u0131 ve ki\u015fisel geli\u015fim planlar\u0131 \u00e7er\u00e7evesinde y\u00f6neticiler bireysel y\u00f6netim dan\u0131\u015fmanl\u0131\u011f\u0131 (Executive Coaching) deste\u011fi de al\u0131yor.  <\/span><\/div>\n

Bir Pfizer \u00e7al\u0131\u015fan\u0131n\u0131 tan\u0131mlayan kelimeler neler?<\/span><\/strong>
Bir Pfizer \u00e7al\u0131\u015fan\u0131n\u0131 \u00f6\u011frenmeye ve kendini geli\u015ftirmeye a\u00e7\u0131k, d\u00fcnyay\u0131 takip eden, dinamik, performans \u00e7\u0131tas\u0131 y\u00fcksek, bilgiye ula\u015fma, \u00e7\u00f6z\u00fcmleme ve sonu\u00e7 \u00fcretme becerileri y\u00fcksek, de\u011fi\u015fime \u00f6nc\u00fcl\u00fck eden bir tak\u0131m arkada\u015f\u0131 olarak tan\u0131mlayabiliriz. <\/span><\/div>\n

Pfizer sosyal yard\u0131m kampanyalar\u0131 d\u00fczenliyor veya bunlara destek veriyor. Sosyal sorumluluk i\u00e7eren projelerde \u00e7al\u0131\u015fanlar\u0131n\u0131z ne gibi bir role sahip? <\/span><\/strong>
Toplumsal duyarl\u0131l\u0131k ve sosyal sorumluluk Pfizer’in vazge\u00e7ilmez bir de\u011feri ve gelene\u011fi.  T\u00fcrkiye’deki sosyal sorumluluk projeleri, 1998 y\u0131l\u0131nda kurulan ve \u015firket \u00e7al\u0131\u015fanlar\u0131ndan olu\u015fan ‘Toplum Tak\u0131m\u0131’yla y\u00fcr\u00fct\u00fcl\u00fcyor. Pfizer T\u00fcrkiye b\u00fcnyesinde \u00e7al\u0131\u015fan ve her y\u0131l de\u011fi\u015fen ki\u015filerden olu\u015fan Pfizer Toplum Tak\u0131m\u0131 \u00fcyeleri, bir y\u0131l boyunca, \u015firketteki g\u00f6revlerinin yan\u0131 s\u0131ra g\u00f6n\u00fcll\u00fc olarak tak\u0131m b\u00fcnyesindeki faaliyetlere kat\u0131l\u0131yor, sosyal sorumluluk projeleri ger\u00e7ekle\u015ftiriyor. Y\u0131lsonundaysa \u00e7al\u0131\u015fanlar g\u00f6revlerini kendi \u00f6nerdikleri \u00e7al\u0131\u015fma arkada\u015flar\u0131na devrediyor. 2007 y\u0131l\u0131nda 9. ya\u015f\u0131n\u0131 kutlayan Pfizer Toplum Tak\u0131m\u0131, ge\u00e7ti\u011fimiz 9 y\u0131l i\u00e7inde e\u011fitim ve sa\u011fl\u0131k alanlar\u0131nda 2.5 Milyon dolar’\u0131n \u00fczerinde malzeme ve nakdi destek sa\u011flad\u0131; hayata ge\u00e7irdi\u011fi projelerle son 9 y\u0131lda 40.000’den fazla gence ula\u015ft\u0131.<\/span><\/div>\n
 <\/div>\n
 <\/div>\n

<\/span><\/span><\/strong><\/div>\n\n

\n\t
\n
\n\t\t\t\"Loading\n <\/div>\n <\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Pfizer, markas\u0131n\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fc ve hayata ge\u00e7irdi\u011fi \u0130K uygulamalar\u0131yla yeti\u015fmi\u015f \u0130nsan Kayna\u011f\u0131n\u0131 b\u00fcnyesine \u00e7ekebiliyor. Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc Ye\u015fim \u00d6zyurt\u00e7u, “Pfizer, ba\u015far\u0131s\u0131n\u0131n ard\u0131nda yatan en \u00f6nemli fakt\u00f6r\u00fcn, \u00e7al\u0131\u015fanlar\u0131 oldu\u011funa ve gelecekteki ba\u015far\u0131s\u0131n\u0131n kayna\u011f\u0131n\u0131n da \u00e7al\u0131\u015fanlar\u0131 olaca\u011f\u0131n\u0131n bilincinde olan bir \u015firket.” diyor. 1957’den beri T\u00fcrkiye’de imalat yapan Pfizer,2000’li y\u0131llarla beraber t\u0131p d\u00fcnyas\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an yenilik\u00e7i tedavileri t\u0131bb\u0131n\u0131n […]<\/p>\n\n

\n\t
\n
\n\t\t\t\"Loading\n <\/div>\n <\/div>\n<\/div>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_elementor_edit_mode":"","_elementor_template_type":"","_elementor_data":"","_elementor_page_settings":null,"_elementor_conditions":[]},"categories":[46,2211],"tags":[],"class_list":{"0":"post-1259","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-is-hayati","7":"category-kariyer-gelisimi"},"yoast_head":"\nPfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc 'Ye\u015fim \u00d6zyurt\u00e7u' | Kariyer Rehberi<\/title>\n<meta name=\"description\" content=\"Pfizer, markas\u0131n\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fc ve hayata ge\u00e7irdi\u011fi \u0130K uygulamalar\u0131yla yeti\u015fmi\u015f \u0130nsan Kayna\u011f\u0131n\u0131 b\u00fcnyesine \u00e7ekebiliyor. Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc Ye\u015fim\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc 'Ye\u015fim \u00d6zyurt\u00e7u'\" \/>\n<meta property=\"og:description\" content=\"Pfizer, markas\u0131n\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fc ve hayata ge\u00e7irdi\u011fi \u0130K uygulamalar\u0131yla yeti\u015fmi\u015f \u0130nsan Kayna\u011f\u0131n\u0131 b\u00fcnyesine \u00e7ekebiliyor. Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc Ye\u015fim\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/\" \/>\n<meta property=\"og:site_name\" content=\"Kariyer Rehberi\" \/>\n<meta property=\"article:published_time\" content=\"2007-12-07T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-03T12:04:52+00:00\" \/>\n<meta name=\"author\" content=\"P\u0131nar Nogay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"P\u0131nar Nogay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 dakika\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc 'Ye\u015fim \u00d6zyurt\u00e7u' | Kariyer Rehberi","description":"Pfizer, markas\u0131n\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fc ve hayata ge\u00e7irdi\u011fi \u0130K uygulamalar\u0131yla yeti\u015fmi\u015f \u0130nsan Kayna\u011f\u0131n\u0131 b\u00fcnyesine \u00e7ekebiliyor. Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc Ye\u015fim","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/","og_locale":"tr_TR","og_type":"article","og_title":"Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc 'Ye\u015fim \u00d6zyurt\u00e7u'","og_description":"Pfizer, markas\u0131n\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fc ve hayata ge\u00e7irdi\u011fi \u0130K uygulamalar\u0131yla yeti\u015fmi\u015f \u0130nsan Kayna\u011f\u0131n\u0131 b\u00fcnyesine \u00e7ekebiliyor. Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc Ye\u015fim","og_url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/","og_site_name":"Kariyer Rehberi","article_published_time":"2007-12-07T00:00:00+00:00","article_modified_time":"2024-07-03T12:04:52+00:00","author":"P\u0131nar Nogay","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"P\u0131nar Nogay","Tahmini okuma s\u00fcresi":"10 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/#article","isPartOf":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/"},"author":{"name":"P\u0131nar Nogay","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/person\/ea0977057f6b311990c570cc6d4c25d0"},"headline":"Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc ‘Ye\u015fim \u00d6zyurt\u00e7u’","datePublished":"2007-12-07T00:00:00+00:00","dateModified":"2024-07-03T12:04:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/"},"wordCount":1986,"commentCount":0,"publisher":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#organization"},"articleSection":["\u0130\u015f Hayat\u0131","Kariyer Geli\u015fimi"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/","url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/","name":"Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc 'Ye\u015fim \u00d6zyurt\u00e7u' | Kariyer Rehberi","isPartOf":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#website"},"datePublished":"2007-12-07T00:00:00+00:00","dateModified":"2024-07-03T12:04:52+00:00","description":"Pfizer, markas\u0131n\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fc ve hayata ge\u00e7irdi\u011fi \u0130K uygulamalar\u0131yla yeti\u015fmi\u015f \u0130nsan Kayna\u011f\u0131n\u0131 b\u00fcnyesine \u00e7ekebiliyor. Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc Ye\u015fim","breadcrumb":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/pfizer-turkiye-ik-direktoru-yesim-ozyurtcu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/www.kariyer.net\/kariyer-rehberi\/"},{"@type":"ListItem","position":2,"name":"Pfizer T\u00fcrkiye \u0130K Direkt\u00f6r\u00fc ‘Ye\u015fim \u00d6zyurt\u00e7u’"}]},{"@type":"WebSite","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#website","url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/","name":"Kariyer Rehberi","description":"\u0130\u015f D\u00fcnyas\u0131yla \u0130lgili Bilmek \u0130stedi\u011finiz Her \u015eey","publisher":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kariyer.net\/kariyer-rehberi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#organization","name":"Kariyer.net","url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/logo\/image\/","url":"https:\/\/www.kariyer.net\/kariyer-rehberi-new\/wp-content\/uploads\/2023\/01\/og-image11.jpg","contentUrl":"https:\/\/www.kariyer.net\/kariyer-rehberi-new\/wp-content\/uploads\/2023\/01\/og-image11.jpg","width":800,"height":800,"caption":"Kariyer.net"},"image":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/person\/ea0977057f6b311990c570cc6d4c25d0","name":"P\u0131nar Nogay","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/330a216cbd1ec8a38c34e372b2be4a261e51e0805bd9186606e000f5efd0f0cf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/330a216cbd1ec8a38c34e372b2be4a261e51e0805bd9186606e000f5efd0f0cf?s=96&d=mm&r=g","caption":"P\u0131nar Nogay"},"description":"Gazeteci olmak i\u00e7in yola \u00e7\u0131karak Eski\u015fehir Anadolu \u00dcniversitesi \u0130leti\u015fim Fak\u00fcltesi\u2019nde Bas\u0131n Yay\u0131n e\u011fitimi ald\u0131. Sekt\u00f6rel yay\u0131nlarda tecr\u00fcbe kazanan, 2007 y\u0131l\u0131nda Kariyer\u2019de Edit\u00f6r olarak \u00e7al\u0131\u015fmaya ba\u015flayan Nogay, 2011\u2019den bu yana Genel Yay\u0131n Y\u00f6netmeni olarak g\u00f6rev yap\u0131yor.","sameAs":["http:\/\/www.kariyer.net\/kariyer-rehberi\/pinar-nogay\/"],"url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/author\/pinar-nogay\/"}]}},"_links":{"self":[{"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/posts\/1259","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/comments?post=1259"}],"version-history":[{"count":1,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/posts\/1259\/revisions"}],"predecessor-version":[{"id":19085,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/posts\/1259\/revisions\/19085"}],"wp:attachment":[{"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/media?parent=1259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/categories?post=1259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/tags?post=1259"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}